Analyzes fundus camera images in seconds to detect major ophthalmic conditions, including macular degeneration, diabetic retinopathy, glaucoma, and epiretinal membrane.
Empowering medical professionals in clinical decision-making.
MFDS Approved (Approval No. 26-1)
※ DOCTOR EYE X-EYE is the product name for DEEPNOID's AI medical software for ophthalmic diagnosis support.
1. Ophthalmic Diseases
Macular Degeneration
Degeneration of the macula causes vision loss and visual field distortion.
Diabetic Retinopathy
Damage to retinal microvessels from diabetes leads to progressive vision loss.
Glaucoma
Optic nerve damage causes gradual visual field loss, often with few early symptoms.
Epiretinal Membrane
A thin membrane forms over the retina, causing visual distortion.
2. Heatmap
The system visualizes key AI-analyzed regions via heatmaps, enhancing diagnostic efficiency for medical professionals.
3. Report
Delivers AI-analyzed diagnostic results and lesion locations through an intuitive interface.
The comprehensive report includes detailed descriptions and visual field symptoms for each condition at a glance.
4. Importance of Early Screening and Diagnosis
- Major ocular conditions—glaucoma, macular degeneration, diabetic retinopathy, and epiretinal membrane—can lead to permanent vision loss if left untreated.
- Early detection is critical, as damage to the optic nerve and retina cannot be reversed.
- Routine fundus examinations enable early detection, allowing clinicians to slow or prevent disease progression.
5. DOCTOR EYE X-EYE Milestones
2024
Development completed for DOCTOR EYE X-EYE
2025
Regulatory approval and commercialization process in progress for DOCTOR EYE X-EYE
MFDS Approved
MFDS Approved (Approval No. D 26-1)